Research
Vision
To create an organisation that supports and drives both translational and clinical research in order to provide world class opportunities in Respiratory and Sleep Health for our local Sunshine Coast community.
Priority Areas & Research Themes
Respiratory infection diseases
Pulmonary vascular disease (pulmonary embolic disease; pulmonary hypertension)
Lung cancer and pleural disease
Airways disease (asthma; COPD; bronchiectasis)
Interstitial Lung Disease
Sleep Disorders
Key members & other stakeholders
Clinician Researchers:
Dr Timothy Baird; Dr James Anderson; Dr Andrew Pattison; Dr Michael Bint; Dr John Goddard; Dr Shiv Erigadoo
Collaborating Organisations:
Sunshine Coast Health Institute; University of Sunshine Coast; University of Queensland; Griffith University; Gallipoli Medical Research Foundation
Collaborating Health Services:
Sunshine Coast Hospital and Health Service; Sunshine Coast University Private Hospital; The Royal Brisbane & Women’s Hospital); Metro South Hospital and Health Service (The Princess Alexandra Hospital)
active reearch grants
Advance Queensland Industry Research Fellowship ($300,000; 2019-2021) – ‘Next-generation diagnostics for chronic lung disease infections. M.Bint & T.Baird
Wishlist/SERTF Collaborative Research Grant ($20000; 2019-2021) – ‘Using metagenomics to improve diagnostics of chronic obstructive pulmonary disease (COPD) pulmonary infections.’ T.Baird
Advance Queensland Industry Research Fellowship ($80,000; 2020-2022) – ‘CoViBac Study: Host response and secondary infection in COVID-19’. T.Baird
SCHI Collaborative Seed Grant ($35,000; 2020-2022) – ‘Characterising the Lung Cancer Microbiome using Next Generation Diagnostics’. T.Baird & M.Bint
Recent Publications
2023
Farquhar D, Choong K, Anderson J et al. Evaluation of a virtual ward model of care and readmission characteristics during the COVID-19 pandemic within an Australian tertiary hospital. Int Med J. 2023; https://doi.org/10.1111/imj.16302
Kearney K, Karen B, Celermajer D… Anderson J et al. Impact of left heart disease risk factors on outcomes in pulmonary arterial hypertension therapy. CHEST. 2023; https://doi.org/10.1016/j.chest.2023.10.037
Samaranayake C, Upham J, Tran K… Anderson J et al. Right ventricular functional recovery assessment with stress echocardiography and cardiopulmonary exercise testing after pulmonary embolism: a pilot prospective multicentre study. July 2023. BMJ Open Respiratory Research 10(1):e001637
Bell PT, Anderson J, Coulter C, Dettrick AJ, Burke A, Baird T. A mariner’s tale: Invasive endotracheal Mycobacterium marinum infection. Respirology Case Reports. 2023;11:e01211. https://doi.org/10.1002/rcr2.1211
2022
Chandresekara S, Lau EM, Anderson J et al. Acute Vasoreactivity Testing and Outcomes in Pulmonary Arterial Hypertension: A Call for Increased Testing. Heart Lung Circ. December 2022. DOI: 10.1016/j.hlc.2022.09.005
Zhang L-Y, Anderson J, Higgins N et al. Screening for obstructive sleep apnoea in patients with serious mental illness. Australasian Psychiatry. June 2022. https://doi.org/10.1177/10398562221108632
Anderson J, Lau E. Pulmonary Hypertension Definition, Classification and Epidemiology in Asia. JACC: Asia. August 2022. https://doi.org/10.1016/j.jacasi.2022.04.008
2021
Kearney K, Anderson J, Cordina R, et al. Impact of left heart disease risk factors on risk stratification and treatment response in pulmonary arterial hypertension. European Heart Journal. 2021; 42, Issue Supplement_1, October 2021, ehab724.1958
Kearney K, Gold J, Anderson J et al. Chronic Thromboembolic Pulmonary Hypertension in Australia and New Zealand: An Analysis of the PHSANZ Registry. Respirology. 2021; (DOI 10.1111/resp14162).
Samaranayake C, Keir G, Slader S, Anderson J et al. Use of direct oral anticoagulants for acute pulmonary embolisms in obesity: a propensity matched multicenter case-control study. ERJ Open Research 2021 (in-press)
Samaranayake C, Keir G, McCabe C, Anderson J et al. Thrombolysis for massive pulmonary embolisms in morbid obesity: a multisite case–control study. ERJ Open Research 2021 7: 00762-2020
Beaton T, Gillis D, Prain K, Anderson J, Goddard J, Baird T. Performance of mysositis-specific antibodies detected on mysositis line immunoassay to diagnose and sub-classify patients with suspected idiopathic inflammatory myopathy, a retrospective records-based review. Rheum Dis. 2021;00:1-9
Goddard J, Tay G, Fry J et al. Multiple Sleep Latency Test: when are 4 naps enough? J Clin Sleep Med. 2021; 17(3):491-497.
2020
Anderson J, Hoang T, Hay K, Tay G. Evaluation of inpatient oxygen therapy in hypercapnic chronic obstructive pulmonary disease. Int Med J. 2020; 51: 654-659.
Ratwatte S, Anderson J, Strange G et al. Pulmonary arterial hypertension with below threshold pulmonary vascular resistance. Eur Resp J. 2020; 56: 1901654.
Anderson J, Lavender M, Lau E et al. Pharmacological Treatment of Pulmonary Arterial Hypertension in Australia: Current Trends and Challenges. Heart Lung Circ. 2020; 29 (10)
Brown SGA, Bint M et al. 2020. Conservative versus interventional treatment for spontaneous pneumothorax. N Engl J Med. 2020;382(5):105-415.
Pattison A, Yasufuku K. Convex-Probe Ultrasonography in Flexible Bronchoscopy. Flexible Bronchoscopy 4th Edition, 2020;8:111-126.
Kanwar MK, Gomberg-Maitland M, Anderson J et al. Risk stratification in pulmonary arterial hypertension using Bayesian analysis. European Respiratory Journal. 2020;56(2):2000008.
Samaranayake C, Anderson J, McCabe C, et al. Direct oral anticoagulants for cancer associated venous thromboembolisms: a systematic review and network meta-analysis. Internal Medicine Journal. 2020;10.1111/imj.15049.
Pattison A, Jeagal L, Yasufuku K, et al. The impact of concordance with a lung cancer diagnosis pathway guideline on treatment access in patients with stage IV lung cancer. Journal of Thoracic Disease. 2020;12(8):4327-4337.
Pattison A, Yasufuku K. Convex-Probe Ultrasonography in Flexible Bronchoscopy. Flexible Bronchoscopy 4th Edition, 2020;8:111-126.
Walczak A, Wilks K, Shakhovskoy R, Baird T et al. ‘COVID-19 in a complex obstetric patient with cystic fibrosis’ COVID-19 in a complex obstetric patient with cystic fibrosis, Infect Dis & Health; doi.org/10.1016/j.idh.2020.07.002.
2019
Gibson J, Baird T, Pandey S et al. The clinical significance of Mycobacterium triplex. Resp Med. 2019;159:105808.
Samaranayake C.B., J. Neill J. and Bint M. Respiratory acute discharge service: a hospital in the home programme for chronic obstructive pulmonary disease exacerbations (RADS Study). Journal of Internal Medicine (IF 1.767). 2019. Epub ahead of print.
Anderson, J., E. Lau, M. Lavender et al. Validation of the REVEAL 2.0 risk score with the Australian and New Zealand pulmonary hypertension registry cohort. European Respiratory Journal (IF 8.332), 2019. 54.
Gadsby, B., C. Samaranayake, M. Windsor, and Bint M, Negative predictive value of a PET-CT scan for occult mediastinal nodal metastases in early stage lung cancer. Respirology (IF 3.078), 2019. 24(S1): p. 161.
Anderson J, Lau E, Lavender M et al. “Retrospective Validation of the REVEAL 2.0 Risk Score With the Australian and New Zealand Pulmonary Hypertension Registry Cohort”. CHEST. 2019; 57 (1):167-172.
2018
Baird T, Thomson R. Diagnosis, classification and epidemiology of pulmonary nontuberculous mycobacterial disease. In: Chalmers JD, Polverino E, Aliberti S. Bronchiectasis (ERS Monograph). Sheffield, European Respiratory Society. 2018:204–221.
Baird T, Theal R. Gleeson et al. Detailed polysomnography in Vietnam veterans with and without post-traumatic stress disorder. JCSM. 2018;14(9):1577-1586.
Baird T, McLeay S, Hervey W. Sleep disturbances in Australian Vietnam Veterans with and without posttraumatic stress disorder. JCSM. 2018;14(5):745-752.
Baird T, Donnan E, Coulter C et al. Multi-drug resistant tuberculosis in Queensland, Australia: an ongoing cross-border challenge. IJTLD. 2018;22(2):206-211.
Baird T, Cooper C Wong et al. Pulmonary schistosomiasis mimicking IgG4-related lung disease. Respirol Case Rep. 2018;6(1):e00276.
Anderson J, Tay G, Denby G et al. Improving service delivery for neuromuscular diseases: a survey of consumers at a tertiary Australian hospital. Brief Communications. Internal Medicine Journal. 2018;48(12):1520-1524.
Anderson J, Curtin D, Higgins N et al. Screening for obstructive sleep apnoea in inpatients with schizophrenia: A feasibility study. Australian & New Zealand Journal of Psychiatry. 2018;52(9):898-899.
2017
Baird T, Cater R. Eather G et al. Mycobacterium shimoidei – a rare pulmonary pathogen, Queensland, Australia. EID. 2017;23(11):1919-22.
Hoy R, Baird T, Yates et al. Artificial stone-associated silicosis: a rapidly emerging occupational lung disease. Occup Environ Med. 2017;0(1-3): doi:10.1136/oemed-2017-104428.
Anderson J, Smith D, Park J, Downey C, Leong M, Tay G, Curtin D. Evaluation of a new simple diagnostic tool for obstructive sleep apnoea. Journal of Sleep Research. 2017; 26 (Suppl . 1): 34-71
Anderson J, Robinson P, Douglas J, Tay G, Robinson J, Curtin D. Consumer-driven service development for neuromuscular disease at The Prince Charles Hospital. Journal of Sleep Research. 2017; 26 (Suppl. 1): 34-71
2016
Anderson J, Fong K, Godbolt D, Leong S, Marshall H. Endobronchial Silicosis and Tuberculosis Presenting as the Right Middle Lobe Syndrome. Journal of Bronchology and Interventional Pulmonology. 2016 Oct;23(4):e35-e37